Cool treatment for birth asphyxia, but what's next?
Levene
Malcolm I
MI
Academic Department of Paediatrics, Leeds General Infirmary, Leeds, UK. m.i.levene@leeds.ac.uk
D000818:Animals; D001238:Asphyxia Neonatorum / Q000150:complications / Q000628:therapy*; D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D007036:Hypothermia, Induced; D020925:Hypoxia-Ischemia, Brain / Q000209:etiology / Q000517:prevention & control*; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008550:Melatonin / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011994:Recombinant Proteins
D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D008278:Magnesium Sulfate; D008550:Melatonin